Showing posts with label mass vaccination. Show all posts
Showing posts with label mass vaccination. Show all posts

Wednesday, April 4, 2018

Meningitis on Campus - An Extremely Timely Lecture by a Public Health Nurse Extraordinaire

Yesterday was the final guest lecture in my Humanitarian Logistics and Healthcare class this semester at the Isenberg School and it was extremely timely and interesting.

The students and I had the privilege of hearing from Ms. Ann Becker, who is the University Health Services (UHS) Public Health Nurse and the Unit Coordinator for the Medical Reserve Corps at  UMass Amherst.
The title of her guest lecture was: Meningitis on Campus - Reaching Students During a Meningitis-B Outbreak.

As some of you may have heard, this past Fall there were two cases of Meningits-B, one in late October, and the other three weeks after. Since no linkages between the two cases could be identified, the Centers for Disease Control (CDC) termed these cases an outbreak. Students get vaccinated for other strains regularly but not for the B strain. And, in early March, the CDC confirmed that another case was diagnosed in a Smith College student, so this is now a 5 College outbreak. 

This disease is very rare but it can progress rapidly with extremely dire effects.  I remember last semester when I was teaching my Transportation and Logistics class at the Isenberg School that one of the students in this class knew the first student to contract meningitis-B because they were both in the same fraternity, and he was involved in helping to raise funds for the student's care and recovery.

10-40% of 16-24 year olds are carriers of this bacteria, and the illness is transmitted through direct contact with secretions. Risk factors include large parties and sharing of drinks, cigarettes, etc., and being stressed and not sleeping enough only increases the probability of contagion. It takes at least a week to identify the meningitis strain from a culture and these were sent both to the Massachusetts DPH and the CDC.

The UMass Amherst campus responded extremely professionally. There had actually been simulation exercises in place for a mass vaccination and I had even blogged about this. This was inspired by the cases in the US a few years back on college campuses, including Princeton University. And, at that time, there was not even a vaccine available in the US (but was in Europe). 

The UMass Amherst campus responded with an emergency call center, since, once the news went out, the staff was inundated with calls. Staffing was identified for the initial vaccination clinics and vaccine supply and cold storage had to be managed. It was interesting to hear that the annual flu clinics also served as a prep for the mass vaccination clinics. UMass Amherst, as a university, is in the business of education, and it was essential to have no disruptions to courses. The healthcare staff, with assistance from nursing students and the Medical Reserve Corp, in 3 hours gave 700 vaccinations. "Being prepared and knowing people" helped in the efficiency of the processes as well as their effectiveness. The cost for 10,000 doses was $1.5 million from Glaxo Smith.

In order to reach students, there were numerous communication media that were utilized - from social media and emails to the notification of parents and having a dedicated strip banner with info on the UMass homepage. Also, the MA DPH sent out messages to every healthcare provider in the state. Two shots are required for the vaccine and there was a one week Thanksgiving break in late November with some students also getting their first vaccines from their home healthcare providers.

UMass Amherst had 4 walkin clinics over consecutive days from noon until 6PM and Ms. Becker showed the class an excellent diagram with the flow of the process, which is something all the Operations students enjoyed and appreciated. It began with the registration and asking for the insurance (if students or insurers could not pay, then (bravo) UMass Amherst covered the expense). Impressively, the number vaccinated reached 1,500 per day with the longest wait time of 20 minutes, which is not bad, given the volume of students as well as the severity of the disease.

It was interesting to hear that the processes were aided by the youth of those vaccinated and that they were all ambulatory.
There are still unknowns, however, since we don't have an accurate count of how many students have received the two shots that are needed, as Ms. Becker pointed out in her lecture.  Interestingly, she also mentioned that, after a year of no more outbreaks, can we be considered "in the clear." They do know that more than 3,000 + students have already had 2 shots.

Our University Health Services are continuing with walk-in clinics, which is great and also reassuring, and they have also done an amazing job in educating students as to proper behavior so that this bacteria does not spread.

We presented our fabulous guest lecturer with a certificate and a gift from the Isenberg School and took the group photo below as a memento.

And, in her last slide of her presentation, featured above, we can see our Chancellor, Dr. Kumble Subbaswamy, "saying": Get Vaccinated.

It was very special to have Ms. Becker speak to my class and her expertise and kindness are truly inspiring. We are very lucky to have her at UHS at UMass Amherst!

Sunday, April 10, 2016

Insights from Meningitis Outbreak at Princeton University and How it Was Managed

Last Thursday, after teaching my Humanitarian Logistics and Healthcare class and holding office hours, which went overtime  because of a great discussion with one of my students who has spent time in Haiti on multiple service trips post the earthquake, I grabbed a quick lunch and then ran in the rain to the UMass Amherst Campus Center.

I had been invited by Mr. Jeff Hescock, who is the Director of Emergency Management and Business Continuity  at UMass Amherst to view an emergency dispensing exercise and to also hear a presentation by Robin Izzo, who is the Director of Environmental Health and Safety at Princeton University.

Mr. Hescock has spoken in my Humanitarian Logistics and Healthcare class and I have, along with several students,  also had an opportunity to take part in a previous year at a mass sheltering exercise at the Mullins Center.

Ms. Izzo was speaking on the meningitis B outbreak that took place at Princeton University not that long ago and the challenges with vaccination, so this was a presentation that I did not want to miss. Plus, nursing students and others were to then take part in a training exercise and simulation associated with a mass vaccination at UMass. A co-organizer of this event was  nurse Ann Becker of the Medical Reserve Corps. Masslive.com posted a nice article and interview with Becker online.

Izzo is also the incident manager at Princeton and is responsible for communications and logistics in emergencies. The first case of meningitis B struck Princeton University in March 2013 and the student who had been on spring break in Florida went right home so he had not been on campus for 9 days. Princeton has about 5,200 undergraduates and 3,000 graduate students.  A few weeks after a 17 year old high school student who had spent time in one of the dorms contracted meningitis B, which is transmitted primarily through saliva.  Afterwards there was a case of  a Princeton student on campus who then attended a wedding in NYC.  Three cases signified that there was a cluster and there were more than three cases in three months.

The health department was notified as well as the Centers for Disease Control (CDC).  Given that almost all the Princeton students live on campus in dormitories and housing, this provided a perfect environment for contagion. Ultimately there were 9 cases, including a Drexel University student who had spent time at Princeton and who then died of this disease, which was quite terrifying. This death made national headlines.

Plus, at that time, there was no licensed vaccine for meningitis B, although Europe and Australia  had a vaccine that it was using.

Pursuing a mass vaccination campaign with an unlicensed vaccine, which was suggested by the CDC,  HAD NEVER BEFORE BEEN DONE IN THE UNITED STATES! Luckily, the FDA quickly approved this vaccine, known as Bexsero, and the first day of vaccinations took place on December 9, 2013. Two doses of this vaccine were needed per patient and, interestingly, it is only for those aged 10 to 25, so many faculty and staff were obviously very apprehensive.

Izzo stated that over the Thanksgiving of 2013 many parents were telling their children at Princeton not to come home since they were so worried about infection. According to Izzo, even if you do get vaccinated, you can still be a carrier for 6 months. Also, among the 8 cases at Princeton, there was no temporal connection.

She described Princeton as being a "really, really scary place" and I know of several faculty who teach there and also students from western Massachusetts who were there during the outbreak.

Information was disseminated to parents and many events during the 2013 - 2014 period were held but with extra care taken. Challenges included big events and reunions. Princeton students who were taking part in study abroad programs went with Cipro, a powerful antibiotic, and were told to look for tell-tale signs of meningitis B, including a rash.

Rizzo also began a mass communications campaign with student videos to emphasize that one should not be sharing drinking cups (although she shared with us that based on a survey 70% at Princeton said that it would be rude to not accept a drink from someone who has used the same cup or glass!).

The campaign included the bright cups below, which had "Mine Not Yours" on them.  She also emphasized the importance of peer pressure in getting the community vaccinated and protected.
She emphasized that it was important to manage the severity and fear but at the beginning the meningitis B was not feared enough.

She urged that the university, health department, and CDC should always speak "with one voice" in such emergencies.   After the first clinic was held,  96-100% of the students received a dose o fthe vaccine.

During the spring and summer of 2014 no overnight guests were allowed in Princeton dorms.  In October 2014, the FDA cleared a new vaccine, made by Pfizer, which requires 3 doses.

On March 13, 2015, Princeton University was considered no more likely than another college as a site for meningitis B.   Interestingly, she noted that there are areas of the US where this contagious bacterial disease is endemic, including parts of the Pacific Northwest and in the past several years there have been other cases at other universities.

During the Q&A I asked her whether Princeton ever considered closing and she said no. Clearly, there are students from around the world there and they may not be able to go home but there are several colleges this past year alone that closed due to norovirus outbreaks. This enabled the institutions to be thoroughly cleaned and sanitized but I suspect that meningitis B that can lurk in one's body for half a year may be another matter entirely.

I have done research on pharmaceutical supply chains with my students, and there is a lot of interest in the Operations Research community on the modeling of vaccine programs, so this was a very educational and timely event.

Many thanks to both Jeff Hescock and Ann Becker for their efforts! Special thanks to Ms. Izzo for her leadership and insights.